Sperling Prostate Center

Tag: Prostate cancer

TRUS Biopsy: The Human Pincushion

Here’s a quote that sums up the issue with a TRUS (transrectal ultrasound) guided prostate biopsy: “Needle biopsy of the prostate is an invasive procedure, which can be associated with complications (including bleeding, pain, and infection) and it is therefore important to maximize the diagnostic information gained.” The word “maximize” would be troubling if it meant sampling as many areas as possible... keep reading

“New” Focal Prostate Cancer Treatment? More Questions Than Answers

Radiofrequency ablation for prostate cancer
“Introducing the ultimate technology in Precision Medicine for Prostate Focal Therapy.” “TSPA is the only technology designed for Prostate Focal Therapy” These bold claims announce the availability of Tissue Sparing Prostate Ablation (TSPA), known by its brand name as Encage. Encage uses a specific type of radiofrequency ablation (RFA), which basically cooks a tumor by keep reading

The Five Problems with TRUS Biopsy

An Important Update on the Rise in Post-Biopsy Infections
Up till now, prostate cancer has been the only tumor cancer diagnosed by random luck. That’s right, random luck. The most common type of prostate biopsy is guided by transrectal ultrasound, or TRUS. It is considered the “gold standard” for prostate biopsy because it’s most widely used by urologists... keep reading
WordPress Image Lightbox